Portal de Periódicos da CAPES

Successful Treatment of Complex Aphthosis With Colchicine and Dapsone

2009; American Medical Association; Volume: 145; Issue: 3 Linguagem: Inglês

10.1001/archdermatol.2008.591

1538-3652

Carrie B. Lynde, Alison J. Bruce, Roy S. Rogers,

Drug-Induced Adverse Reactions

Objective To investigate the effectiveness of colchicine and dapsone, 2 corticosteroid-sparing anti-inflammatory agents, in the treatment of patients with complex aphthosis (recurrent oral and genital aphthous ulcers or severe, almost constant, multiple oral aphthae in the absence of Behçet syndrome). Design Retrospective review of medical records. Setting Tertiary care medical clinic. Patients Fifty-five patients with complex aphthosis evaluated and treated at Mayo Clinic between January 1, 1998, and July 31, 2007. All the patients were treated according to a therapeutic ladder, starting with colchicine and adding dapsone to treatment of patients who did not have a substantial response (>75% improvement) to colchicine or who discontinued colchicine use because of adverse effects. Main Outcome Measures A substantial response to therapy with colchicine alone, dapsone alone, or colchicine and dapsone combined. Results Most patients (44 [80%]) had a substantial response to therapy and had no serious adverse effects. Conclusions Colchicine and dapsone are effective, safe therapies for the treatment of complex aphthosis. Colchicine and dapsone, 2 established drugs also used for gout and leprosy, respectively, and for other dermatologic disorders, should be considered efficacious in the treatment of complex aphthosis.